Edition:
United Kingdom

Teligent Inc (TLGT.OQ)

TLGT.OQ on NASDAQ Stock Exchange Global Select Market

3.37USD
23 Oct 2018
Change (% chg)

$-0.02 (-0.59%)
Prev Close
$3.39
Open
$3.35
Day's High
$3.37
Day's Low
$3.32
Volume
5,004
Avg. Vol
84,546
52-wk High
$6.47
52-wk Low
$2.43

Latest Key Developments (Source: Significant Developments)

Teligent Inc Announces FDA Approval Of Fluocinonide Ointment Usp, 0.05%
Tuesday, 2 Oct 2018 

Oct 2 (Reuters) - Teligent Inc ::TELIGENT, INC. ANNOUNCES FDA APPROVAL OF FLUOCINONIDE OINTMENT USP, 0.05%.TELIGENT INC - PLANNING TO LAUNCH FLUOCINONIDE OINTMENT USP, 0.05% IN Q4 OF 2018.  Full Article

Teligent Inc QTRLY Loss Per Share $0.39
Wednesday, 8 Aug 2018 

Teligent Inc ::TELIGENT, INC. ANNOUNCES SECOND QUARTER 2018 RESULTS.Q2 REVENUE FELL 9 PERCENT TO $16.8 MILLION.EXPANSION OF BUENA, NEW JERSEY MANUFACTURING FACILITY IS ON TRACK.QTRLY LOSS PER SHARE $0.39.  Full Article

Teligent Announces FDA Approval Of Lidocaine And Prilocaine Cream
Monday, 2 Jul 2018 

July 2 (Reuters) - Teligent Inc ::TELIGENT, INC. ANNOUNCES FDA APPROVAL OF LIDOCAINE AND PRILOCAINE CREAM USP, 2.5%/2.5%.TELIGENT INC - PLAN TO LAUNCH LIDOCAINE AND PRILOCAINE CREAM USP, 2.5%/2.5% IN Q3 OF 2018.  Full Article

Teligent Announces FDA Approval Of Fluocinonide Gel
Wednesday, 20 Jun 2018 

June 20 (Reuters) - Teligent Inc ::TELIGENT, INC. ANNOUNCES FDA APPROVAL OF FLUOCINONIDE GEL, 0.05%.TELIGENT INC - PLANNING TO LAUNCH FLUOCINONIDE GEL, 0.05% IN Q3 2018.  Full Article

Teligent Reports Q1 Loss Per Share $0.09
Tuesday, 8 May 2018 

May 8 (Reuters) - Teligent Inc ::TELIGENT, INC. ANNOUNCES FIRST QUARTER 2018 RESULTS.TELIGENT INC <<>> Q1 REVENUE FELL 26 PCT TO $14.5 MLN.TELIGENT INC <<>>- QTRLY SHR LOSS $0.09.  Full Article

Prosight Management Reports A Passive Stake Of 6.8 Pct In Teligent
Monday, 7 May 2018 

May 7 (Reuters) - Teligent Inc ::PROSIGHT MANAGEMENT LP REPORTS A PASSIVE STAKE OF 6.8 PERCENT IN TELIGENT AS OF APRIL 27 - SEC FILING.  Full Article

Teligent Inc Announces FDA Approval Of Clobetasol Propionate Cream
Tuesday, 17 Apr 2018 

April 17 (Reuters) - Teligent Inc ::TELIGENT, INC. ANNOUNCES FDA APPROVAL OF CLOBETASOL PROPIONATE CREAM USP, 0.05%.TELIGENT INC - RECEIVED APPROVAL OF CO'S ABBREVIATED NEW DRUG APPLICATION FROM U.S. FDA OF CLOBETASOL PROPIONATE CREAM USP, 0.05%.  Full Article

Teligent Appoints Damian Finio As Chief Financial Officer
Friday, 26 Jan 2018 

Jan 26 (Reuters) - Teligent Inc ::TELIGENT, INC. ANNOUNCES THE APPOINTMENT OF DAMIAN FINIO AS CHIEF FINANCIAL OFFICER.TELIGENT INC - FINIO WILL SUCCEED JENNIFFER COLLINS, WHO IS LEAVING CO TO PURSUE PERSONAL AND PROFESSIONAL OPPORTUNITIES.  Full Article

TELIGENT ANNOUNCES FDA GENERIC APPROVAL OF HYDROCORTISONE BUTYRATE LOTION 0.1%
Wednesday, 22 Nov 2017 

Nov 22 (Reuters) - Teligent Inc ::TELIGENT, INC. ANNOUNCES FIRST FDA GENERIC APPROVAL OF HYDROCORTISONE BUTYRATE LOTION 0.1%.TELIGENT, INC. ANNOUNCES FIRST FDA GENERIC APPROVAL OF HYDROCORTISONE BUTYRATE LOTION 0.1%.TELIGENT INC- ‍EXPECT TO LAUNCH HYDROCORTISONE BUTYRATE LOTION 0.1%​ IN Q1 OF 2018.  Full Article

TELIGENT ANNOUNCES FDA APPROVAL OF ERYTHROMYCIN TOPICAL SOLUTION USP, 2%
Tuesday, 21 Nov 2017 

Nov 21 (Reuters) - Teligent Inc ::TELIGENT, INC. ANNOUNCES FDA APPROVAL OF ERYTHROMYCIN TOPICAL SOLUTION USP, 2%.TELIGENT INC- ‍EXPECT TO LAUNCH ERYTHROMYCIN TOPICAL SOLUTION USP, 2% BEFORE THE END 2017.  Full Article

BRIEF-Teligent Reports Q1 Loss Per Share $0.09

* TELIGENT INC- QTRLY SHR LOSS $0.09 Source text for Eikon: Further company coverage: